You are using an outdated browser. Please upgrade your browser to improve your experience.

deafness-encephaloneuropathy-obesity-valvulopathy syndrome

Disease Summary
Associated Targets (1)
Tbio

1


Mondo Description Deafness-encephaloneuropathy-obesity-valvulopathy syndrome is a rare mitochondrial disease with marked clinical variability typically characterized by encephalomyopathy, kidney disease (nephrotic syndrome), optic atrophy, early-onset deafness, pancytopenia, obesity, and cardiac disease (valvulopathy). Additionally, macrocephaly, intellectual disability, hyperlactatemia, elevated lactate/pyruvate ratio, insulin-dependent diabetes, livedo reticularis, liver dysfunction and seizures have also been associated.
Uniprot Description An autosomal recessive multisystem disorder characterized by early-onset deafness, optic atrophy, mild mental retardation, peripheral neuropathy, obesity, livedo reticularis, and cardiac valvulopathy.
Disease Ontology Description A primary coenzyme Q10 deficiency that has_material_basis_in an autosomal recessive mutation of PDSS1 on chromosome 10p12.1.
Mondo Term and Equivalent IDs
MONDO:0013837:  deafness-encephaloneuropathy-obesity-valvulopathy syndrome
Orphanet:254898: 
UMLS:C3553354: